CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
Cyanoacrylate (Octylseal )device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01514383
NCT01514383Phase 4Completed

Evaluation of Octylseal as a Topical Surgical Skin Incision Adhesive in General Surgery: A Case Series

Medline Industries·interventional·Posted Jan 23, 2012·Updated May 7, 2019

In Brief

A Phase 4 clinical trial evaluating Cyanoacrylate (Octylseal ) for Wounds. Completed, enrolled 34 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate how surgical adhesive is used.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWounds
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 23, 2012
Enrollment StartJan 1, 2012
Primary CompletionSep 1, 2012
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.4 years ago

Interventions

Cyanoacrylate (Octylseal )device

surgical adhesive